Dalit Vaizel-Ohayon

Title: Dalit Vaizel-Ohayon: Innovator in Chemokine Modulation

Introduction

Dalit Vaizel-Ohayon is a prominent inventor based in Beit-HaKerem, Israel. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents that target chemokine receptors. With a total of 4 patents to his name, his work is paving the way for innovative treatments in various medical applications.

Latest Patents

One of Dalit's latest patents focuses on peptides for inhibiting chemokine binding to chemokine receptors. This invention introduces novel peptidic or peptidomimetic agents or small molecules designed to modulate the biological effects of chemokines. The therapeutic agents are engineered to bind to specific chemokines, thereby influencing the biological interaction between the target ligand and its respective receptor. These peptides can function as either agonist ligands or antagonists, and they share consensus sequences that characterize different families or categories of modulator peptides.

Career Highlights

Dalit Vaizel-Ohayon is currently associated with Biokine Therapeutics Ltd., where he continues to advance his research and development efforts. His innovative work in the field of chemokine modulation has garnered attention and respect within the scientific community.

Collaborations

Dalit collaborates with notable colleagues, including Amnon Peled and Orly Eizenberg, who contribute to his research endeavors and help drive forward the mission of Biokine Therapeutics Ltd.

Conclusion

Dalit Vaizel-Ohayon's contributions to the field of biochemistry, particularly in chemokine modulation, highlight his role as an influential inventor. His ongoing research and innovative patents are set to make a significant impact in therapeutic applications.